Security key
69366J200
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT)
CUSIP: 69366J200
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 81,782,297
- Total 13F shares
- 58,378,537
- Share change
- +286,713
- Total reported value
- $2,626,676,199
- Put/Call ratio
- 76%
- Price per share
- $45.00
- Number of holders
- 173
- Value change
- +$33,782,408
- Number of buys
- 95
- Number of sells
- 80
Report period
Q2 2019
Institutions
173
Top holders
10
PTCT full security history
Newer quarter: Q3 2019
Previous quarter: Q1 2019
PTC THERAPEUTICS, INC. SEC filings
PTC THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 69366J200
Recent filing periods:
Top shareholders of PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
6.1%
|
4,968,189
|
$187,002,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5%
|
4,107,898
|
$154,621,000 | — | 31 Mar 2019 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
4.6%
|
3,744,376
|
$140,923,000 | — | 31 Mar 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.3%
|
3,524,542
|
$132,664,000 | — | 31 Mar 2019 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.6%
|
2,905,393
|
$109,359,000 | — | 31 Mar 2019 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
3.1%
|
2,514,271
|
$94,637,000 | — | 31 Mar 2019 | |
| STATE STREET CORP |
13F
|
Company |
3.1%
|
2,500,926
|
$94,135,000 | — | 31 Mar 2019 | |
| FMR LLC |
13F
|
Company |
3%
|
2,436,735
|
$91,719,000 | — | 31 Mar 2019 | |
| SCOPIA CAPITAL MANAGEMENT LP |
13F
|
Company |
2.6%
|
2,106,190
|
$79,277,000 | — | 31 Mar 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.6%
|
2,092,195
|
$78,750,000 | — | 31 Mar 2019 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
2.2%
|
1,814,260
|
$68,289,000 | — | 31 Mar 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.9%
|
1,519,700
|
$57,202,000 | — | 31 Mar 2019 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.7%
|
1,418,479
|
$53,392,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.3%
|
1,092,077
|
$41,104,000 | — | 31 Mar 2019 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.3%
|
1,086,776
|
$40,906,000 | — | 31 Mar 2019 | |
| Boxer Capital, LLC |
13F
|
Company |
1.2%
|
1,000,000
|
$37,640,000 | — | 31 Mar 2019 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.1%
|
913,936
|
$34,400,000 | — | 31 Mar 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
907,300
|
$34,151,000 | — | 31 Mar 2019 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.1%
|
882,636
|
$33,223,000 | — | 31 Mar 2019 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.86%
|
700,000
|
$26,348,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.83%
|
681,348
|
$25,645,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.82%
|
669,778
|
$25,211,000 | — | 31 Mar 2019 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.81%
|
662,587
|
$24,940,000 | — | 31 Mar 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.75%
|
614,027
|
$23,112,000 | — | 31 Mar 2019 | |
| Spark Investment Management LLC |
13F
|
Company |
0.69%
|
566,000
|
$21,304,000 | — | 31 Mar 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.66%
|
538,001
|
$20,250,000 | — | 31 Mar 2019 | |
| Elk Creek Partners, LLC |
13F
|
Company |
0.57%
|
467,537
|
$17,598,000 | — | 31 Mar 2019 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.57%
|
463,137
|
$17,432,000 | — | 31 Mar 2019 | |
| S.c.a. Candriam |
13F
|
Individual |
0.57%
|
462,523
|
$17,410,000 | — | 31 Mar 2019 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.49%
|
400,000
|
$15,056,000 | — | 31 Mar 2019 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.48%
|
396,476
|
$14,923,000 | — | 31 Mar 2019 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.45%
|
370,183
|
$13,934,000 | — | 31 Mar 2019 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.45%
|
365,674
|
$13,764,000 | — | 31 Mar 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.44%
|
357,431
|
$13,454,000 | — | 31 Mar 2019 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.38%
|
307,100
|
$11,559,245 | — | 31 Mar 2019 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.37%
|
302,917
|
$11,402,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.37%
|
301,704
|
$11,356,000 | — | 31 Mar 2019 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.37%
|
299,431
|
$11,271,000 | — | 31 Mar 2019 | |
| Atom Investors LP |
13F
|
Company |
0.36%
|
298,451
|
$11,234,000 | — | 31 Mar 2019 | |
| CITIGROUP INC |
13F
|
Company |
0.35%
|
283,073
|
$10,655,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.34%
|
275,545
|
$10,371,000 | — | 31 Mar 2019 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.34%
|
274,712
|
$10,340,000 | — | 31 Mar 2019 | |
| Invesco Ltd. |
13F
|
Company |
0.31%
|
252,079
|
$9,488,000 | — | 31 Mar 2019 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.3%
|
242,628
|
$9,133,000 | — | 31 Mar 2019 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.29%
|
240,493
|
$9,050,000 | — | 31 Mar 2019 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.29%
|
237,611
|
$8,943,000 | — | 31 Mar 2019 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.29%
|
237,000
|
$8,921,000 | — | 31 Mar 2019 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.27%
|
220,500
|
$8,300,000 | — | 31 Mar 2019 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.27%
|
217,807
|
$8,198,000 | — | 31 Mar 2019 | |
| Opaleye Management Inc. |
13F
|
Company |
0.26%
|
213,800
|
$8,047,000 | — | 31 Mar 2019 |
Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q2 2019
As of 30 Jun 2019,
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) was held by
173 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,378,537 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., FRANKLIN RESOURCES INC, PRICE T ROWE ASSOCIATES INC /MD/, RTW INVESTMENTS, LP, Point72 Asset Management, L.P., FMR LLC, STATE STREET CORP, ORBIMED ADVISORS LLC, and GREAT POINT PARTNERS LLC.
This page lists
173
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
169
Q2 2019 holders
173
Holder diff
4
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.